Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 2/2015

01-02-2015 | Original Paper

Socioeconomic Gradients in Internalized Stigma Among 4,314 Persons with HIV in Sub-Saharan Africa

Author: Alexander C. Tsai

Published in: AIDS and Behavior | Issue 2/2015

Login to get access

Abstract

The stigma attached to HIV is a major public health problem given its adverse impacts on HIV prevention and on the psychosocial wellbeing of persons with HIV. In this study, I apply a novel method to data from the Demographic and Health Surveys to identify persons with HIV who were aware of their seropositivity at the time of the survey. The pooled dataset includes 4,314 persons with HIV in Cameroon, Ethiopia, Gabon, Kenya, Lesotho, Malawi, Rwanda, Swaziland, Tanzania, Uganda, Zambia, and Zimbabwe. My findings indicate that nearly one-fifth of study participants provided survey responses consistent with internalization of stigmatizing beliefs. Furthermore, in multivariable regression models, striking socioeconomic gradients in internalized stigma were observed. A clear implication of my findings is that the adverse health and psychosocial impacts of HIV stigma are likely concentrated among those with the fewest socioeconomic resources for managing and resisting it.
Appendix
Available only for authorised users
Literature
1.
2.
Pryor JB, Reeder GD, Vinacco R, Kott TL. The instrumental and symbolic functions of attitudes towards persons with AIDS. J Appl Soc Psychol. 1989;19(5):377–404.CrossRef
3.
4.
Cassens BJ. Social consequences of the acquired immunodeficiency syndrome. Ann Intern Med. 1985;103(5):768–71.CrossRefPubMed
5.
Link BG, Cullen FT, Struening E, Shrout PE. A modified labeling theory approach to mental disorders: an empirical assessment. Am Sociol Rev. 1989;54(3):400–23.CrossRef
6.
Pantelic M, Shenderovich Y, Cluver L, Boyes M. Predictors of internalised HIV-related stigma: a systematic review of studies in sub-Saharan Africa. Health Psychol Rev (in press).
7.
Berger BE, Ferrans CE, Lashley FR. Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. Res Nurs Health. 2001;24(6):518–29.CrossRefPubMed
8.
Holzemer WL, Uys LR, Chirwa ML, et al. Validation of the HIV/AIDS Stigma Instrument—PLWA (HASI-P). AIDS Care. 2007;19(8):1002–12.CrossRefPubMed
9.
10.
Kalichman SC, Simbayi LC, Cloete A, Mthembu PP, Mkhonta RN, Ginindza T. Measuring AIDS stigmas in people living with HIV/AIDS: the Internalized AIDS-Related Stigma Scale. AIDS Care. 2009;21(1):87–93.CrossRefPubMed
11.
Tsai AC, Weiser SD, Steward WT, et al. Evidence for the reliability and validity of the internalized AIDS-related stigma scale in rural Uganda. AIDS Behav. 2013;17(1):427–33.CrossRefPubMedCentralPubMed
12.
Nyblade L, Pande R, Mathur S, et al. Disentangling HIV and AIDS stigma in Ethiopia, Tanzania, and Zambia. Washington, DC: International Center for Research on Women; 2003.
13.
Kalichman SC, Simbayi LC, Jooste S, et al. Development of a brief scale to measure AIDS-related stigma in South Africa. AIDS Behav. 2005;9(2):135–43.CrossRefPubMed
14.
Mishra V, Agrawal P, Alva S, Gu Y, Wang S. Changes in HIV-related knowledge and behaviors in sub-Saharan Africa. DHS Comparative Reports No. 24. Calverton: ICF Macro; 2009.
15.
Genberg BL, Hlavka Z, Konda KA, et al. A comparison of HIV/AIDS-related stigma in four countries: negative attitudes and perceived acts of discrimination towards people living with HIV/AIDS. Soc Sci Med. 2009;68(12):2279–87.CrossRefPubMedCentralPubMed
16.
Maman S, Abler L, Parker L, et al. A comparison of HIV stigma and discrimination in five international sites: the influence of care and treatment resources in high prevalence settings. Soc Sci Med. 2009;68(12):2271–8.CrossRefPubMedCentralPubMed
17.
18.
Link BG. Understanding labeling effects in the area of mental disorders: an assessment of the effects of expectations of rejection. Am Sociol Rev. 1987;52(1):96–112.CrossRef
19.
Link BG, Mirotznik J, Cullen FT. The effectiveness of stigma coping orientations: can negative consequences of mental illness labeling be avoided? J Health Soc Behav. 1991;32(3):302–20.CrossRefPubMed
20.
Takada S, Weiser SD, Kumbakumba E, et al. The dynamic relationship between social support and HIV stigma in rural Uganda. Ann Behav Med. 2014;48(1):26–37.CrossRefPubMed
21.
Simbayi LC, Kalichman S, Strebel A, Cloete A, Henda N, Mqeketo A. Internalized stigma, discrimination, and depression among men and women living with HIV/AIDS in Cape Town, South Africa. Soc Sci Med. 2007;64(9):1823–31.CrossRefPubMedCentralPubMed
22.
Tsai AC, Bangsberg DR, Frongillo EA, et al. Food insecurity, depression and the modifying role of social support among people living with HIV/AIDS in rural Uganda. Soc Sci Med. 2012;74(12):2012–9.CrossRefPubMedCentralPubMed
23.
Fife BL, Wright ER. The dimensionality of stigma: a comparison of its impact on the self of persons with HIV/AIDS and cancer. J Health Soc Behav. 2000;41(1):50–67.CrossRefPubMed
24.
Govindasamy D, Ford N, Kranzer K. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. AIDS. 2012;26(16):2059–67.CrossRefPubMed
25.
Tsai AC. Reliability and validity of depression assessment among persons with HIV in sub-Saharan Africa: systematic review and meta-analysis. J Acquir Immune Defic Syndr. 2014;66(5):503–11.CrossRefPubMed
26.
Tsai AC, Weiser SD, Petersen ML, Ragland K, Kushel MB, Bangsberg DR. A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV. Arch Gen Psychiatry. 2010;67(12):1282–90.CrossRefPubMedCentralPubMed
27.
Tsai AC, Karasic DH, Hammer GP, et al. Directly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: a randomized controlled trial. Am J Public Health. 2013;103(2):308–15.CrossRefPubMedCentralPubMed
28.
Martinez P, Tsai AC, Muzoora C, et al. Reversal of the kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans. J Acquir Immune Defic Syndr. 2014;65(4):456–62.CrossRefPubMed
29.
Katz IT, Ryu AE, Onuegbu AG, et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc. 2013;16(Suppl 2):18640.PubMedCentralPubMed
30.
Kinsler JJ, Wong MD, Sayles JN, Davis C, Cunningham WE. The effect of perceived stigma from a health care provider on access to care among a low-income HIV-positive population. AIDS Patient Care STDs. 2007;21(8):584–92.CrossRefPubMed
31.
Gilmore N, Somerville MA. Stigmatization, scapegoating and discrimination in sexually transmitted diseases: overcoming ‘them’ and ‘us’. Soc Sci Med. 1994;39(9):1339–58.CrossRefPubMed
32.
Bateson MC, Goldsby R. Thinking AIDS: the social response to the biological threat. Reading: Addison-Wesley; 1988.
33.
Kalusopa T, Dicks R, Osei-Boateng C, editors. Social protection schemes in Africa. African Labour Research Network: Windhoek; 2012.
34.
Castro A, Farmer P. Understanding and addressing AIDS-related stigma: from anthropological theory to clinical practice in Haiti. Am J Public Health. 2005;95(1):53–9.CrossRefPubMedCentralPubMed
35.
Neuberg SL, Smith DM, Asther T. Why people stigmatize: toward a biocultural framework. In: Heatherton TF, Kleck RE, Hebl MR, Hull JG, editors. The social psychology of stigma. New York: The Guilford Press; 2000. p. 31–61.
36.
Kurzban R, Leary MR. Evolutionary origins of stigmatization: the functions of social exclusion. Psychol Bull. 2001;127(2):187–208.CrossRefPubMed
37.
Portes A, Sensenbrenner J. Embeddedness and immigration: notes on the social determinants of economic action. Am J Sociol. 1993;98(6):1320–50.CrossRef
38.
Niehaus I. Death before dying: understanding AIDS stigma in the South Africa lowveld. J S Afr Stud. 2007;33(4):845–60.CrossRef
39.
Farmer P, Leandre F, Mukherjee JS, et al. Community-based approaches to HIV treatment in resource-poor settings. Lancet. 2001;358(9279):404–9.CrossRefPubMed
40.
Wolfe WR, Weiser SD, Leiter K, et al. The impact of universal access to antiretroviral therapy on HIV stigma in Botswana. Am J Public Health. 2008;98(10):1865–71.CrossRefPubMedCentralPubMed
41.
Maman S, van Rooyen H, Stankard P, et al. NIMH Project Accept (HPTN 043): results from in-depth interviews with a longitudinal cohort of community members. PLoS One. 2014;9(1):e87091.CrossRefPubMedCentralPubMed
42.
43.
Nyanzi-Wakholi B, Lara AM, Watera C, Munderi P, Gilks C, Grosskurth H. The role of HIV testing, counselling, and treatment in coping with HIV/AIDS in Uganda: a qualitative analysis. AIDS Care. 2009;21(7):903–8.CrossRefPubMed
44.
Wagner GJ, Ghosh-Dastidar B, Garnett J, Kityo C, Mugyenyi P. Impact of HIV antiretroviral therapy on depression and mental health among clients With HIV in Uganda. Psychosom Med. 2012;74(9):883–90.CrossRefPubMed
45.
Tsai AC, Bangsberg DR, Bwana M, et al. How does antiretroviral treatment attenuate the stigma of HIV? Evidence from a cohort study in rural Uganda. AIDS Behav. 2013;17(8):2725–31.CrossRefPubMedCentralPubMed
46.
Mbonye M, Nakamanya S, Birungi J, King R, Seeley J, Jaffar S. Stigma trajectories among people living with HIV (PLHIV) embarking on a life time journey with antiretroviral drugs in Jinja, Uganda. BMC Public Health. 2013;13(1):804.CrossRefPubMedCentralPubMed
47.
Venkataramani AS, Haberer JE, Thirumurthy H, et al. CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda. AIDS. 2014;28(8):1221–6.PubMed
48.
Mishra V, Vaessen M, Boerma JT, et al. HIV testing in national population-based surveys: experience from the Demographic and Health Surveys. Bull World Health Organ. 2006;84(7):537–45.CrossRefPubMedCentralPubMed
49.
Mishra V, Assche SB, Greener R, et al. HIV infection does not disproportionately affect the poorer in sub-Saharan Africa. AIDS. 2007;21(Suppl 7):S17–28.CrossRefPubMed
50.
UNAIDS. National AIDS programmes: a guide to monitoring and evaluation. UNAIDS/00.17E. Geneva: Joint United Nations Programme on HIV/AIDS; 2000.
51.
Burris S. Stigma, ethics and policy: a commentary on Bayer’s “Stigma and the ethics of public health: Not can we but should we”. Soc Sci Med. 2008;67(3):473–5 discussion 476–477.CrossRefPubMed
52.
Pallitto CC, O’Campo P. Community level effects of gender inequality on intimate partner violence and unintended pregnancy in Colombia: testing the feminist perspective. Soc Sci Med. 2005;60(10):2205–16.CrossRefPubMed
53.
Filmer D, Pritchett LH. Estimating wealth effects without expenditure data—or tears: an application to educational enrollments in states of India. Demography. 2001;38(1):115–32.PubMed
54.
Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6.CrossRefPubMed
55.
Yelland LN, Salter AB, Ryan P. Performance of the modified Poisson regression approach for estimating relative risks from clustered prospective data. Am J Epidemiol. 2011;174(8):984–92.CrossRefPubMed
56.
Williams R. Using the margins command to estimate and interpret adjusted predictions and marginal effects. Stata J. 2012;12(2):308–31.
57.
Yebei VN, Fortenberry JD, Ayuku DO. Felt stigma among people living with HIV/AIDS in rural and urban Kenya. Afr Health Sci. 2008;8(2):97–102.PubMedCentralPubMed
58.
Siedner MJ, Ng CK, Bassett IV, Katz IT, Bangsberg DR, Tsai AC. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002–2013: a meta-analysis. Clin Infect Dis. doi:10.​1093/​cid/​ciu1137.
59.
Shinsasa O, Simbayi L. Nelson Mandela/HSRC study of HIV/AIDS: South African national HIV prevalence, behavioral risks and mass media, household survey 2002. Cape Town: Human Sciences Research Council; 2002.
60.
61.
Kalichman SC, Simbayi LC. HIV testing attitudes, AIDS stigma, and voluntary HIV counselling and testing in a black township in Cape Town, South Africa. Sex Transm Infect. 2003;79(6):442–7.CrossRefPubMedCentralPubMed
62.
Kalichman SC, Simbayi L. Traditional beliefs about the cause of AIDS and AIDS-related stigma in South Africa. AIDS Care. 2004;16(5):572–80.CrossRefPubMed
63.
Chan BT, Weiser SD, Boum Y, et al. Persistent HIV-related stigma in rural Uganda during a period of increasing HIV incidence despite treatment expansion. AIDS. 2015;29(1):83–90.CrossRefPubMed
64.
Mall S, Middelkoop K, Mark D, Wood R, Bekker LG. Changing patterns in HIV/AIDS stigma and uptake of voluntary counselling and testing services: the results of two consecutive community surveys conducted in the Western Cape, South Africa. AIDS Care. 2013;25(2):194–201.CrossRefPubMed
65.
66.
67.
Farrimond HR, Joffe H. Pollution, peril and poverty: a British study of the stigmatization of smokers. J Community Appl Social Psychol. 2006;16(6):481–91.CrossRef
68.
Tsai AC, Bangsberg DR, Kegeles SM, et al. Internalized stigma, social distance, and disclosure of HIV seropositivity in rural Uganda. Ann Behav Med. 2013;46(3):285–94.CrossRefPubMed
69.
Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bull World Health Organ. 2004;82(4):299–307.PubMedCentralPubMed
70.
Musheke M, Bond V, Merten S. Individual and contextual factors influencing patient attrition from antiretroviral therapy care in an urban community of Lusaka, Zambia. J Int AIDS Soc. 2012;15(Suppl 1):17366.PubMedCentral
71.
Gourlay A, Birdthistle I, Mburu G, Iorpenda K, Wringe A. Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2013;16(1):18588.CrossRefPubMedCentralPubMed
72.
Musheke M, Ntalasha H, Gari S, et al. A systematic review of qualitative findings on factors enabling and deterring uptake of HIV testing in sub-Saharan Africa. BMC Public Health. 2013;13:220.CrossRefPubMedCentralPubMed
73.
Shelton JD, Cassell MM, Adetunji J. Is poverty or wealth at the root of HIV? Lancet. 2005;366(9491):1057–8.CrossRefPubMed
74.
Lachaud JP. HIV prevalence and poverty in Africa: micro- and macro-econometric evidences applied to Burkina Faso. J Health Econ. 2007;26(3):483–504.CrossRefPubMed
75.
Msisha WM, Kapiga SH, Earls F, Subramanian SV. Socioeconomic status and HIV seroprevalence in Tanzania: a counterintuitive relationship. Int J Epidemiol. 2008;37(6):1297–303.CrossRefPubMedCentralPubMed
76.
Hargreaves JR, Glynn JR. Educational attainment and HIV-1 infection in developing countries: a systematic review. Trop Med Int Health. 2002;7(6):489–98.CrossRefPubMed
77.
Hargreaves JR, Bonell CP, Boler T, et al. Systematic review exploring time trends in the association between educational attainment and risk of HIV infection in sub-Saharan Africa. AIDS. 2008;22(3):403–14.CrossRefPubMed
78.
Hargreaves JR, Davey C, White RG. Does the ‘inverse equity hypothesis’ explain how both poverty and wealth can be associated with HIV prevalence in sub-Saharan Africa? J Epidemiol Community Health. 2013;67(6):526–9.CrossRefPubMed
79.
80.
Victora CG, Vaughan JP, Barros FC, Silva AC, Tomasi E. Explaining trends in inequities: evidence from Brazilian child health studies. Lancet. 2000;356(9235):1093–8.CrossRefPubMed
81.
Frohlich KL, Potvin L. Transcending the known in public health practice: the inequality paradox: the population approach and vulnerable populations. Am J Public Health. 2008;98(2):216–21.CrossRefPubMedCentralPubMed
82.
Link BG, Northridge ME, Phelan JC, Ganz ML. Social epidemiology and the fundamental cause concept: on the structuring of effective cancer screens by socioeconomic status. Milbank Q. 1998;76(3):375–402.CrossRefPubMedCentralPubMed
83.
de Walque D. How does the impact of an HIV/AIDS information campaign vary with educational attainment? Evidence from rural Uganda. J Dev Econ. 2007;84(2):686–714.CrossRef
84.
Tsai AC. A typology of structural approaches to HIV prevention: a commentary on Roberts and Matthews. Soc Sci Med. 2012;75(9):1562–7 discussion 1568–1571.CrossRefPubMedCentralPubMed
85.
Garcia Calleja JM, Marum LH, Carcamo CP, Kaetano L, Muttunga J, Way A. Lessons learned in the conduct, validation, and interpretation of national population based HIV surveys. AIDS. 2005;19(Suppl 2):S9–17.CrossRef
86.
Mishra V, Barrere B, Hong R, Khan S. Evaluation of bias in HIV seroprevalence estimates from national household surveys. Sex Transm Infect. 2008;84(Suppl 1):i63–70.CrossRefPubMedCentralPubMed
87.
Barnighausen T, Bor J, Wandira-Kazibwe S, Canning D. Correcting HIV prevalence estimates for survey nonparticipation using Heckman-type selection models. Epidemiology. 2011;22(1):27–35.CrossRefPubMed
88.
Pettifor A, MacPhail C, Suchindran S, Delany-Moretlwe S. Factors associated with HIV testing among public sector clinic attendees in Johannesburg, South Africa. AIDS Behav. 2010;14(4):913–21.CrossRefPubMed
89.
90.
Pitpitan EV, Kalichman SC, Eaton LA, et al. AIDS-related stigma, HIV testing, and transmission risk among patrons of informal drinking places in Cape Town, South Africa. Ann Behav Med. 2012;43(3):362–71.CrossRefPubMedCentralPubMed
91.
92.
Hogan DR, Salomon JA, Canning D, Hammitt JK, Zaslavsky AM, Barnighausen T. National HIV prevalence estimates for sub-Saharan Africa: controlling selection bias with Heckman-type selection models. Sex Transm Infect. 2012;88(Suppl 2):i17–23.CrossRefPubMedCentralPubMed
93.
94.
de Paula A, Shapira G, Todd PE. How beliefs about HIV status affect risky behaviors: evidence from Malawi. J Appl Econom. 2014;29(6):944–64.CrossRef
95.
96.
Oster E, Shoulson I, Dorsey ER. Optimal expectations and limited medical testing: evidence from Huntington Disease. Am Econ Rev. 2013;103(2):804–30.CrossRef
97.
Yoder PS, Nyblade L. Comprehension of questions in the Tanzania AIDS Indicator Survey. Calverton: ORC Macro; 2004.
98.
Nyblade L, MacQuarrie K, Phillip F, et al. Measuring HIV stigma: results of a field test in Tanzania. Washington, DC: U.S. Agency for International Development; 2005.
99.
Jones EE, Nisbett RE. The actor and the observer: divergent perceptions of the causes of behavior. In: Jones EE, Kanhouse DE, Kelley HH, Nisbett RE, Valins S, Weiner B, editors. Attribution: perceiving the causes of behavior. Morristown: General Learning Press; 1972. p. 79–94.
Metadata
Title
Socioeconomic Gradients in Internalized Stigma Among 4,314 Persons with HIV in Sub-Saharan Africa
Author
Alexander C. Tsai
Publication date
01-02-2015
Publisher
Springer US
Published in
AIDS and Behavior / Issue 2/2015
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0993-7

Other articles of this Issue 2/2015

AIDS and Behavior 2/2015 Go to the issue

Original Paper

Strategies for Recruiting Steady Male Partners of Female Sex Workers for HIV Research

Original Paper

Cultural Adaptation of the Brief COPE for Persons Living with HIV/AIDS in Southern India

Original Paper

HIV-Positive Status Disclosure in Patients in Care in Rural South Africa: Implications for Scaling Up Treatment and Prevention Interventions

Original Paper

Development of a Brief Substance Use Sensation Seeking Scale: Validation and Prediction of Injection-Related Behaviors

Guest Editorial

Achieving and Advancing the Goals of the National HIV/AIDS Strategy for the United States

Original Paper

“Was it a Mistake to Tell Others That You are Infected with HIV?”: Factors Associated with Regret Following HIV Disclosure Among People Living with HIV in Five Countries (Mali, Morocco, Democratic Republic of the Congo, Ecuador and Romania). Results from a Community-Based Research
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits